FAS and neoplasm: Molecules that are ligands for NK receptors such as NKG2D and cell death receptors Fas/CD95 as well as adhesion molecules that enhance the recognition and killing of tumor cells by cytotoxic T lymphocytes are expressed on cancer cells that survive chemotherapy treatment [24].